Cancer Therapy News and Research

RSS

New biological principle and therapeutic goal for cancer treatment

Pioneering research on leukaemia cells can have identified their vulnerable spot. This new knowledge can now be used to produce more effective medicines.

14 Sep 2004

Cancers, including colon, prostate, and leukemia, continue to grow unchecked

Many cancers, including colon, prostate, and leukemia, continue to grow unchecked because they do not respond to a signal to die and stop proliferating from Transforming Growth Factor-beta (TGF-b).

8 Sep 2004

Genomic researchers and Canadian cancer treatment specialists meet in Halifax in order to improve cancer treatment outcomes

The Canadian Association of Radiation Oncologists and leading genomic cancer researchers will meet, Thursday, September 9 to 12th, 2004 at the Westin Nova Scotian Hotel in Halifax, to present research studies' results and to confer on methods to zero in on how to begin to utilize genomics, proteomics, and radiation, to improve cancer treatment outcomes for patients.

8 Sep 2004

Counseling for breast cancer patients means healthier diets, reduced smoking and stronger immune systems

Regular psychological counseling for breast cancer patients may do more than just lower their stress and anxiety. A new study says the right kind of intervention can also mean healthier diets, reduced smoking, and most surprising of all – a stronger immune system.

2 Sep 2004

Ambitious decades-long investigation into the causes of breast cancer aims to recruit 100,000 women

Details of a unique, ambitious and decades-long investigation into the causes of breast cancer - The Breakthrough Generations Study - were revealed today by Breakthrough Breast Cancer, the UK's leading breast cancer charity, and The Institute of Cancer Research, one of the world's leading cancer research organisations.

1 Sep 2004

Cinical trial to evaluate breakthrough breast cancer treatment

Virginia Commonwealth University’s Massey Cancer Center will host 20 medical experts from around the United States on Sept. 9 to prepare for a 3,000-patient phase III clinical trial that will evaluate a breakthrough breast cancer treatment.

30 Aug 2004

Private health insurers are failing to cover vital cancer treatment

According to a report released by the charity, most PMI policies do not cover cancer patients throughout the course of their illness. This means that funding for vital cancer treatment is being suddenly withdrawn, often at a critical time, when patients are at their most vulnerable.

25 Aug 2004

Powerful new cancer-fighting property of Herceptin

For many patients with advanced breast cancer, the cancer drug Herceptin (trastuzumab) has offered new hope when traditional cancer drugs failed to work, shrinking tumors and sending some patients into remission.

23 Aug 2004

New database about a group of genes associated with multidrug resistance in cancerous tumors

Scientists at the National Cancer Institute, have created a database of information about a group of genes associated with multidrug resistance in cancerous tumors.

23 Aug 2004

Physicians today perform more colonoscopies than necessary

A colonoscopy allows a physician look inside the entire large intestine, from the lowest part, the rectum, all the way up through the colon to the lower end of the small intestine.

16 Aug 2004

The largest North American breast cancer prevention trial ever undertaken has reached its goal of enrolling 19,000 women

The largest North American breast cancer prevention trial ever undertaken, the Study of Tamoxifen and Raloxifene (STAR), reached its goal of enrolling 19,000 women to the trial in June 2004, a month earlier than originally expected.

13 Aug 2004

Concern over media coverage surrounding the Tronado microwave treatment of cancer

The Australian Medical Association (WA) today expressed concern over media coverage surrounding the Tronado microwave treatment of cancer.

13 Aug 2004

Australian university signs multi-million dollar anti-cancer research deal

Australia's University of Newcastle Research Associates (TUNRA) Ltd has signed a licensing agreement worth approximately $10 million with the biotechnology company Psiron Ltd to develop anti-cancer treatments.

5 Aug 2004

Moderate exercise helps beat fatigue from prostate radiation

Men who get a moderate amount of exercise during radiation for prostate cancer are better able to cope with the fatigue the treatment can cause, researchers from Scotland report in the journal Cancer.

5 Aug 2004

One-third of U.S. adults use some form of alternative medicine

More than one-third of U.S. adults use some form of alternative medicine such as herbal supplements and other therapies, showed in a nationwide survey by NIH's National Center for Complementary and Alternative Medicine published in May 2004.

2 Aug 2004

Light-sensitive probe to help doctors spot breast cancer

A light-sensitive probe is being developed to help doctors spot breast cancer in some of the 70,000 American women each year whose malignancies fail to show up in needle biopsies.

26 Jul 2004

Bladder-sparing treatment shows promise against cancer

For patients with invasive bladder cancer, treatment has typically meant an operation to remove the bladder and nearby organs. This requires up to a week in the hospital and leaves patients with a reconstructed bladder or urostomy bag.

21 Jul 2004

Australian collaboration to produce cancer immunotherapy vaccines

A Brisbane based biomedical company, Tissue Therapies Limited (TIS) and the Queensland Institute of Medical Research (QIMR) have agreed on the terms of a new collaboration aimed at developing Tissue Therapies' VitroGro® cell growth technology as a platform to produce cancer immunotherapy vaccines.

21 Jul 2004

Chemotherapy aimed at both cancer cells and their genetically normal cellular 'microenvironment' might improve the success of breast cancer treatment

In the first comprehensive survey of gene activity in each cell type composing normal and malignant breast tissue, scientists at Dana-Farber Cancer Institute have identified genes in non-cancerous supporting cells that can spur the growth of breast cancer cells.

20 Jul 2004

Two out of three survivors of childhood cancer have at least one chronic or late-occurring health problem following their cancer therapy

A review in the July/August issue of “CA: A Cancer Journal for Clinicians” reports that two out of three survivors of childhood cancer have at least one chronic or late-occurring health problem following their cancer therapy, with about one in three having serious or life-threatening complications. These effects are often seen decades after therapy.

15 Jul 2004